• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Acarix

0.26 SEK

-1.12 %

Less than 1K followers

ACARIX

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.12 %
-2.76 %
-7.03 %
-1.31 %
-5.54 %
-4.34 %
-51.57 %
-74.35 %
-96.42 %

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Read more
Market cap
319.4M SEK
Turnover
84.2K SEK
Revenue
7.36M
EBIT %
-652.31 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
ShowingAll content types

Forum discussions
On my journey in search of a new Revenio, in a country where vague Finland-Swedish was spoken and which was ruled by Carl XVI Gustaf, I came across a company called Acarix. And I’m not comparing this to be a new Revenio. For the diagnosis of coronary artery disease, a common basic...
9/8/2021, 5:11 AM
by Fisu
9
Expected SEK 79 million share issue now underway: https://acarix.com/wp-content/uploads/2021/11/acarixpralmeria-prospekteng.pdf
12/6/2021, 12:06 AM
by Pohjolan Eka
3
Tärkeimmät talousuutiset | Kauppalehti – 27 Jun 19 Acarix CADScor®System included in NICE guidelines (UK) Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä. Here’s a slightly older bulletin. An interesting product, which has...
9/8/2021, 7:32 AM
by PP2020
3
Interesting that the analyst firm is also an advisor.. Are they also an investor?
9/8/2021, 5:33 AM
by Yoda
3
Redeye’s website does have a Disclosures section for the company in question, which states whether Redeye owns the company. In this case, it does not. redeye.se Acarix Disclosures - Redeye Discover the latest equity research on Acarix.
9/8/2021, 2:45 PM
by Llopardi
2
PubMed Economic Analysis of the CADScor System for Ruling Out Coronary Artery... The CADScor System is a potentially cost-saving test for the diagnosis of CAD. When initiated before the use of non-invasive cardiac imaging tests such as computed tomography coronary angiography, the...
9/8/2021, 5:40 AM
by PP2020
2
News from America has arrived; I don’t know how to post it here. Thanks in advance
10/27/2021, 11:02 AM
by Hollitupa
1
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13/8
2026

Interim report Q2'26

5/11
2026

Interim report Q3'26

11/2
2027

Annual report '26

Regulatory press release2026-06-17 16:30

Kommuniké från årsstämma i Acarix AB

Acarix
Regulatory press release2026-06-17 16:30

Announcement from the annual general meeting in Acarix AB

Acarix
Regulatory press release2026-06-16 19:00

Valberedningens förslag inför årsstämman i Acarix AB (publ) den 17 juni 2026

Acarix

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-06-16 19:00

Proposals of the Nomination Committee for the Annual General Meeting of Acarix AB (publ) on June 17, 2026

Acarix
Press release2026-05-19 11:12

Redeye: Acarix (Q1 Review): Continued US traction and improved cost base

Acarix
Regulatory press release2026-05-18 22:30

KALLELSE TILL ÅRSSTÄMMA I Acarix AB

Acarix
Regulatory press release2026-05-18 22:30

NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB

Acarix
Regulatory press release2026-05-18 08:00

Acarix Publishes Interim Report, January – March 2026

Acarix
Regulatory press release2026-05-04 14:23

Acarix ändrar datum för publicering av delårsrapport för Q1 2026

Acarix
Regulatory press release2026-05-04 14:23

Acarix Changes Publication Date for Q1 2026 Interim Report

Acarix
Regulatory press release2026-04-15 13:00

Acarix AB’s Annual Report 2025

Acarix
Regulatory press release2026-04-15 13:00

Acarix AB’s Årsredovisning 2025

Acarix
Press release2026-04-07 13:00

ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM'S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS

Acarix
Press release2026-02-13 13:05

Redeye: Acarix (Q4 review): A solid end to 2025

Acarix
Regulatory press release2026-02-12 08:00

Acarix Publishes Year-End Report 2025

Acarix
Press release2026-02-11 09:20

Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System

Acarix
Press release2026-02-04 09:20

Acarix Receives EU MDR Certification for the CADScor®System

Acarix
Regulatory press release2025-12-08 08:47

ACARIX GENOMFÖR EN RIKTAD EMISSION OM CIRKA 33,4 MSEK

Acarix
Regulatory press release2025-12-08 08:47

ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION

Acarix
Press release2025-11-06 08:45

Invitation to presentation of Acarix´s third quarter 2025 report

Acarix